Prognostic markers in node-negative breast cancer: A prospective study
Open Access
- 23 March 2004
- Vol. 59B (1) , 24-31
- https://doi.org/10.1002/cyto.b.20003
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Prognostic Factors in Breast CancerArchives of Pathology & Laboratory Medicine, 2000
- S-phase fraction and breast cancer - a decade of experienceBreast Cancer Research and Treatment, 1998
- S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen- receptor-positive breast cancerBreast Cancer Research and Treatment, 1998
- Low cathepsin D and low plasminogen activator type 1 inhibitor in tumor cytosols defines a group of node negative breast cancer patients with low risk of recurrence.Breast Cancer Research and Treatment, 1998
- Lack of prognostic value of cathepsin D levels for predicting short term outcomes of breast cancer patientsCancer Letters, 1997
- Flow cytometry in node‐positive breast cancer: Cancer and leukemia group B protocol 8869Cytometry, 1995
- Consensus review of the clinical utility of DNA cytometry in carcinoma of the breastBreast Cancer Research and Treatment, 1993
- Indicators of Prognosis in Node-Negative Breast CancerNew England Journal of Medicine, 1990
- Relation of tumor size, lymph node status, and survival in 24,740 breast cancer casesCancer, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958